Adamed Pharma S.A.   Report issue

For profit
Founded: Warsaw Poland (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2020
NCT04277156
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Adamed Pharma S.A.

Active Ingredients

Drugs in Other Trials (2)

lactobacillus reuteri (1 trial)

lactobacillus rhamnosus (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2